Optomed Oyj (OPTOMED) Stock Overview

Optomed Oyj, a medical technology company, manufactures and sells handheld fundus cameras and screening software in Finland, rest of Europe, and internationally. It operates in two segments, Devices and Software segments. The company develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary care professionals; and provides professional IT consulting services for government institutions. It offers camera products under the Optomed Smartscope Pro, Optomed Aurora, and Optomed Polaris brand names, as well as OEM cameras under the Pictor Plus and Pictor Prestige (Volk), Visuscout 100 (Zeiss), Fundus Module 300 (The Haag-Streit), and Signal (Topcon) brand names. The company also provides Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases; Avenue Archive, an application software for displaying, archiving, and transmitting healthcare information; Avenue Telemedicine, a telemedicine solution for remote image analysis; Avenue AI, a diabetic retinopathy screening service; Avenue Sync, a software for integrating fundus camera to the hospital image archive and worklist server; and Avenue Flow, an eyecare management software. In addition, it offers Avenue Cancer Screen, a screening process management software for breast, cervical, and colorectal cancer; Optomed RIS, a software solution for healthcare imaging units for enhancing the diagnostic process and treatment decisions; Sectra PACS, a modular system for healthcare providers; Optomed Service Portal, a support function for healthcare units; Facad, a tracing software for visible light imaging and cephalometric measurements; and Sectra PACS Pathology, which allows scanned glass slides to be distributed and diagnosed. It sells its products through OEMs, distributors, and direct sales to hospitals, eye clinics, and optician chains and stores. Optomed Oyj was incorporated in 2004 and is headquartered in Oulu, Finland.